Brief: DURECT Corporation Reports Q4 And FY22 Financial Results

DURECT

07/03/2023 21:13

March 7 (Reuters) - Durect Corp  DRRX.O :
    * ORATION REPORTS FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL
RESULTS AND AHFIRM TRIAL UPDATE
    * TOPLINE DATA FROM AHFIRM TRIAL EXPECTED IN 2023
    * QTRLY LOSS PER SHARE OF $0.46
    * Q4 EARNINGS PER SHARE VIEW $-0.55 -- REFINITIV IBES DATA
    * TOTAL REVENUES WERE $3.3 MILLION AND NET LOSS WAS $10.5
MILLION
FOR THREE MONTHS ENDED DECEMBER 31, 2022
    * Q4 REVENUE VIEW $3.5 MILLION -- REFINITIV IBES DATA

Source text for Eikon:  ID:nPn84Sc6ja 
Further company coverage:  DRRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))